Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
This designation reaffirms that NantHealth is a trusted leader in utilization review and is committed to quality and transformative healthcare,...
NantHealth to Showcase Advancements in Technology that Enable Value-Based Care and Discuss Technology’s Role in Reducing Healthcare Costs Culver City,...
Culver City, CA – June 13, 2019 – NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its...
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Culver City, California and San Diego – June 19, 2018 – NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present...